Komal Gupta

Komal Gupta serves as Chief Executive Officer at Windlas Biotech Limited. Windlas Biotech Limited operates in the pharmaceuticals sector with approximately 730.0 employees. The company is headquartered in Gurgaon, Haryana.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 500 executive contacts are available in Haryana.
• • Our database includes 201,469 c suite-level executives.

GoDaddy Hosting Outlook Microsoft Office 365 Amazon AWS Zoho CRM Google Font API WordPress.org Mobile Friendly Google Tag Manager Apache Data Analytics Remote

contract manufacturing pharmaceutical manufacturing contract development & manufacturing organization cdmo pharmaceutical products nutraceutical products product development commercial manufacturing complex drugs dosage forms tablets capsules injections syrups cardiovascular products cns-neuro products generic medicines innovative solutions affordable healthcare research & development export markets trade generics manufacturing facilities quality standards gmp iso certifications indian pharmaceutical industry global market presence customer satisfaction employee reviews competitive landscape market growth drug research healthcare solutions underserved patients innovative formulations product lifecycle management distribution network regulatory compliance financial stability strategic partnerships market expansion mechanical or industrial engineering pharmaceuticals medical mobile devices mobile internet information technology & services

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Komal Gupta in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Windlas Biotech Limited.

Komal Gupta's Position in the MessageCEO Database

• •Komal Gupta is 1 of 1 verified executive contact we track at Windlas Biotech Limited.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •500 verified executive contacts in Haryana are in the database.
• •6 verified contacts work at pharmaceuticals companies in the 730.0 employee range (same size as Windlas Biotech Limited).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Komal Gupta directly?

Komal Gupta's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Windlas Biotech Limited. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Komal Gupta work for?

Komal Gupta is Chief Executive Officer at Windlas Biotech Limited, a company in the pharmaceuticals sector with 730.0 employees. The company is based in Gurgaon, Haryana.

Can I pitch or sell to Komal Gupta?

As Chief Executive Officer at Windlas Biotech Limited, Komal Gupta is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Komal Gupta directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Komal Gupta in?

Komal Gupta works in the pharmaceuticals industry as Chief Executive Officer at Windlas Biotech Limited. MessageCEO provides verified contact information for executives across all major industries.

Is Komal Gupta's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Komal Gupta's profile is kept up-to-date with the latest available information.

Last updated: June 21, 2026